2m 2m 2m 2m 2m 2m 2m
ABSCI (ABSI)
NASDAQ
$11.03+$0.28 (+2.60%)
Price as of Oct 02, 2026 5:23 PM EDT- $1.8BMarket Cap
- 202.82%1-Year Change
- BiotechnologyIndustry
ABSCI (ABSI)
$11.03+$0.28 (+2.60%)
ABSI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.75 | ||
Change | -$0.02 (-0.19%) | ||
Open | $10.80 | ||
High | $11.27 | ||
Low | $10.55 | ||
Previous Close | $10.77 | ||
Volume | 4,608,584 | ||
30-Day Average Volume | 3,909,670 | ||
1-Week Change | 3.91% | ||
1-Month Change | 21.61% | ||
1-Year Change | 202.82% | ||
3-Year Change | 714.39% | ||
5-Year Change | -13.45% | ||
Fundamentals | |||
Shares Outstanding | 171.6M | ||
Total Assets | $268.9M | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $318,000.00 | ||
Net Income | -$33.2M | ||
Free Cash Flow | -$27.6M | ||
EBIT | -$33.2M | ||
EBITDA | -$30.5M | ||
Net Working Capital | $188.7M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -57 | ||
Enterprise Value/Revenue | 5,463 | ||
P/B | 7 | ||
P/E | -51 | ||
PEG | 5 | ||
Price/Free Cash Flow | -67 | ||
Price/Operating Cash Flow | -67 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue